We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$214M
AUM Growth
-$55.1M
Cap. Flow
-$57.5M
Cap. Flow %
-26.83%
Top 10 Hldgs %
32.55%
Holding
81
New
13
Increased
14
Reduced
26
Closed
22

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$5.49M
2
TMO icon
Thermo Fisher Scientific
TMO
+$4.2M
3
RVTY icon
Revvity
RVTY
+$3.48M
4
TECH icon
Bio-Techne
TECH
+$2.83M
5
NVRO
NEVRO CORP.
NVRO
+$2.83M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$6.09M
2
HCA icon
HCA Healthcare
HCA
+$5.82M
3
CELG
Celgene Corp
CELG
+$5.22M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.72M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.19M

Sector Composition

Rank Sector Weight
1 Healthcare 95.03%
2 Energy 1.01%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDY icon
51
Dr. Reddy's Laboratories
RDY
$10.3B
$1.82M 0.85%
278,565
-96,435
-26% -$676K
BLUE
52
DELISTED
bluebird bio
BLUE
$1.71M 0.8%
772
-772
-50% -$1.96M
PBYI icon
53
Puma Biotechnology
PBYI
$459M
$1.7M 0.79%
25,000
-10,000
-29% -$749K
AKRX
54
DELISTED
Akorn Inc
AKRX
$1.69M 0.79%
+90,099
New +$2.44M
AGIO icon
55
Agios Pharmaceuticals
AGIO
$2.01B
$1.64M 0.76%
20,019
BMRN icon
56
BioMarin Pharmaceuticals
BMRN
$13.7B
$1.62M 0.76%
20,000
-55,000
-73% -$4.72M
TSRO
57
DELISTED
TESARO, Inc.
TSRO
$1.61M 0.75%
28,271
+3,271
+13% +$210K
TDOC icon
58
Teladoc Health
TDOC
$1.21B
$1.61M 0.75%
+40,000
New +$1.51M
ACAD icon
59
Acadia Pharmaceuticals
ACAD
$5.07B
-65,000
Closed -$1.96M
CI icon
60
Cigna
CI
$72.5B
-30,000
Closed -$6.09M
EW icon
61
Edwards Lifesciences
EW
$53.3B
-60,000
Closed -$2.25M
JNJ icon
62
Johnson & Johnson
JNJ
$627B
-30,000
Closed -$4.19M
LH icon
63
Labcorp
LH
$25.9B
-23,280
Closed -$3.19M
NVO
64
Novo Nordisk
NVO
$202B
-100,000
Closed -$2.68M
PODD icon
65
Insulet
PODD
$9.88B
-50,000
Closed -$3.45M
THC icon
66
Tenet Healthcare
THC
$21.1B
-200,000
Closed -$3.03M
CTLT
67
DELISTED
CATALENT, INC.
CTLT
-75,000
Closed -$3.08M
SGEN
68
DELISTED
Seagen Inc. Common Stock
SGEN
-27,500
Closed -$1.47M
CLVS
69
DELISTED
Clovis Oncology, Inc.
CLVS
-35,000
Closed -$2.38M
GWPH
70
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-30,000
Closed -$3.96M
PTLA
71
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-40,000
Closed -$1.95M
DPLO
72
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-100,000
Closed -$2.01M
ESRX
73
DELISTED
Express Scripts Holding Company
ESRX
-35,000
Closed -$2.61M
AET
74
DELISTED
Aetna Inc
AET
-20,000
Closed -$3.61M
KND
75
DELISTED
Kindred Healthcare
KND
-225,000
Closed -$2.18M

Similar funds

Sivik Global Healthcare's Q1 2018 Portfolio in Review

As of Q1 2018, Sivik Global Healthcare held 81 positions worth $214M, down 20% from $269M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Sivik Global Healthcare withdrew a net $57.5M in Q1 2018, closing 22 positions and reducing 26 holdings. Its most notable exit was Cigna, an estimated $6.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 93% a quarter earlier, followed by Energy and Financials.

Against the trend, Sivik Global Healthcare opened a new position in Cardinal Health worth $5.01M.

  • Sivik Global Healthcare's largest Q1 2018 buy was Cardinal Health: 80,000 shares worth $5.01M.
  • Sivik Global Healthcare added most to Viatris in Q1 2018, an estimated $1.71M increase.
  • Sivik Global Healthcare's biggest Q1 2018 reduction was HCA Healthcare, cutting an estimated $5.82M.
  • Sivik Global Healthcare fully exited Cigna in Q1 2018, selling an estimated $6.09M.
  • Sivik Global Healthcare's ten largest holdings make up 33% of its $214M portfolio in Q1 2018.
  • Sivik Global Healthcare opened 13 new positions and closed 22 in Q1 2018.
  • Sivik Global Healthcare's portfolio value fell 20% quarter-over-quarter to $214M.

Based on Sivik Global Healthcare's 13F filing for Q1 2018, filed 8 May 2018.